Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist

被引：1
|
作者：
Shenoy, Niraj [1 ]
Pagliaro, Lance [1 ]
机构：
[1] Mayo Clin, Dept Med Oncol, 200 First St SW, Rochester, MN 55905 USA
来源：
EUROPEAN UROLOGY | 2018年 / 73卷 / 02期
关键词：
HIF1-ALPHA;
D O I：
10.1016/j.eururo.2017.10.007
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / 305
页数：4
相关论文
共 50 条
  • [1] Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist
    Ferguson, James E., III
    Matin, Surena F.
    EUROPEAN UROLOGY, 2017, 71 (06) : 987 - 987
  • [2] Targeting renal cell carcinoma with a HIF-2 antagonist
    Chen, Wenfang
    Hill, Haley
    Christie, Alana
    Kim, Min Soo
    Holloman, Eboni
    Pavia-Jimenez, Andrea
    Homayoun, Farrah
    Ma, Yuanqing
    Patel, Nirav
    Yell, Paul
    Hao, Guiyang
    Yousuf, Qurratulain
    Joyce, Allison
    Pedrosa, Ivan
    Geiger, Heather
    Zhang, He
    Chang, Jenny
    Gardner, Kevin H.
    Bruick, Richard K.
    Reeves, Catherine
    Hwang, Tae Hyun
    Courtney, Kevin
    Frenkel, Eugene
    Sun, Xiankai
    Zojwalla, Naseem
    Wong, Tai
    Rizzi, James P.
    Wallace, Eli M.
    Josey, John A.
    Xie, Yang
    Xie, Xian-Jin
    Kapur, Payal
    McKay, Renee M.
    Brugarolas, James
    NATURE, 2016, 539 (7627) : 112 - +
  • [3] Targeting renal cell carcinoma with a HIF-2 antagonist
    Wenfang Chen
    Haley Hill
    Alana Christie
    Min Soo Kim
    Eboni Holloman
    Andrea Pavia-Jimenez
    Farrah Homayoun
    Yuanqing Ma
    Nirav Patel
    Paul Yell
    Guiyang Hao
    Qurratulain Yousuf
    Allison Joyce
    Ivan Pedrosa
    Heather Geiger
    He Zhang
    Jenny Chang
    Kevin H. Gardner
    Richard K. Bruick
    Catherine Reeves
    Tae Hyun Hwang
    Kevin Courtney
    Eugene Frenkel
    Xiankai Sun
    Naseem Zojwalla
    Tai Wong
    James P. Rizzi
    Eli M. Wallace
    John A. Josey
    Yang Xie
    Xian-Jin Xie
    Payal Kapur
    Renée M. McKay
    James Brugarolas
    Nature, 2016, 539 : 112 - 117
  • [4] Targeting HIF-2 Alpha in Renal Cell Carcinoma
    Ramsha Ahmed
    Moshe C. Ornstein
    Current Treatment Options in Oncology, 2023, 24 (9) : 1183 - 1198
  • [5] Targeting HIF-2 Alpha in Renal Cell Carcinoma
    Ahmed, Ramsha
    Ornstein, Moshe C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1183 - 1198
  • [6] Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy
    Martinez-Saez, Olga
    Borau, Pablo Gajate
    Alonso-Gordoa, Teresa
    Molina-Cerrillo, Javier
    Grande, Enrique
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 117 - 123
  • [7] Therapeutic target for HIF-2α antagonist-resistant clear cell renal cell carcinoma
    Son, D. H.
    Hong, S. H.
    Hwang, H. J.
    Kim, E. S.
    Park, S. Y.
    Yoon, Y. E.
    EUROPEAN UROLOGY, 2023, 83
  • [8] Targeting HIF-2α and anemia: A therapeutic breakthrough for clear-cell renal cell carcinoma
    Rioja, Patricia
    Rey-Cardenas, M.
    De Velasco, Guillermo
    CANCER TREATMENT REVIEWS, 2024, 129
  • [9] SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA
    Son, Da Hyeon
    Lee, Young Ju
    Kim, Hyo Eun
    Kim, Eun Song
    Park, Sung Yul
    Yoon, Young Eun
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1067 - E1068
  • [10] HIF-2 alpha targeting with a novel RNAi delivery platform as therapy for renal cell carcinoma
    Wong, S.
    Cheng, W.
    Wakefield, D.
    Almeida, A.
    Blokhin, A.
    Almeida, L.
    Hamilton, H.
    Subbotin, V.
    Hegge, J.
    Bertin, S.
    Milarch, T.
    Schmidt, R.
    Neal, Z.
    Perillo-Nicholas, A.
    Zhang, G.
    Montez, J.
    Andersen, A.
    Rozema, D.
    Lewis, D.
    Kanner, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S71 - S72
12345